Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics President and CEO Issues Letter to Stockholders Highlighting Key Accomplishments and Outlines Milestones for 2018
Atossa Genetics Appoints Carl Novina, MD, PhD as Scientific Advisor
Atossa Genetics Announces Pricing of $1.4 Million Registered Direct Offering
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!